278 related articles for article (PubMed ID: 29341328)
1. Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.
Luder CM; Nordmann TM; Ramelyte E; Mühleisen B; Kerl K; Guenova E; Dummer R
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):926-934. PubMed ID: 29341328
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous histiocytoses in children.
Fraitag S; Emile JF
Histopathology; 2022 Jan; 80(1):196-215. PubMed ID: 34958507
[TBL] [Abstract][Full Text] [Related]
3. The non-Langerhans' cell histiocytoses in childhood.
Burgdorf WH; Zelger B
Cutis; 1996 Sep; 58(3):201-7. PubMed ID: 8886534
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
[TBL] [Abstract][Full Text] [Related]
6. The Non-Langerhans Cell Histiocytoses (Rare Histiocytoses) - Clinical Aspects and Therapeutic Approaches.
Classen CF; Minkov M; Lehrnbecher T
Klin Padiatr; 2016 Nov; 228(6-07):294-306. PubMed ID: 27846659
[TBL] [Abstract][Full Text] [Related]
7. OCT2 expression in histiocytoses.
Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
[TBL] [Abstract][Full Text] [Related]
8. [Histiocytic diseases in childhood and adolescence].
Vokuhl C; Oschlies I; Klapper W; Leuschner I
Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
[TBL] [Abstract][Full Text] [Related]
9. Non-Langerhan's cell histiocytoses of the skin.
Ansari NA; Al-Ratrout JT
Saudi Med J; 2003 Dec; 24(12):1296-9. PubMed ID: 14710272
[TBL] [Abstract][Full Text] [Related]
10. Juvenile and adult xanthogranuloma: A 30-year single-center experience and review of the disorder and its relationship to other histiocytoses.
Salari B; Dehner LP
Ann Diagn Pathol; 2022 Jun; 58():151940. PubMed ID: 35378409
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase is a marker of cutaneous Langerhans' cell histiocytosis ("X")-a comparative study with S100 protein.
Kanitakis J; Fantini F; Pincelli C; Hermier C; Schmitt D; Thivolet J
Anticancer Res; 1991; 11(2):635-9. PubMed ID: 1648331
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
Geerlinks AV; Abla O
Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
[TBL] [Abstract][Full Text] [Related]
13. Aggressive histiocytic disorders that can involve the skin.
Newman B; Hu W; Nigro K; Gilliam AC
J Am Acad Dermatol; 2007 Feb; 56(2):302-16. PubMed ID: 17097374
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
[TBL] [Abstract][Full Text] [Related]
15. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
[TBL] [Abstract][Full Text] [Related]
16. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.
Auerbach A; Aguilera NS
Semin Diagn Pathol; 2023 Nov; 40(6):420-428. PubMed ID: 37258365
[TBL] [Abstract][Full Text] [Related]
17. [Histiocytoses: General classification and molecular criteria].
Emile JF; Charlotte F; Chassagne-Clement C; Copin MC; Fraitag S; Mokhtari K; Moreau A
Presse Med; 2017 Jan; 46(1):46-54. PubMed ID: 26952138
[TBL] [Abstract][Full Text] [Related]
18. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
Emile JF; Abla O; Fraitag S; Horne A; Haroche J; Donadieu J; Requena-Caballero L; Jordan MB; Abdel-Wahab O; Allen CE; Charlotte F; Diamond EL; Egeler RM; Fischer A; Herrera JG; Henter JI; Janku F; Merad M; Picarsic J; Rodriguez-Galindo C; Rollins BJ; Tazi A; Vassallo R; Weiss LM;
Blood; 2016 Jun; 127(22):2672-81. PubMed ID: 26966089
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases.
Bonometti A; Gliozzo J; Moltrasio C; Bagnoli F; Berti E
Australas J Dermatol; 2021 May; 62(2):e162-e169. PubMed ID: 33125722
[TBL] [Abstract][Full Text] [Related]
20. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
Ravindran A; Dasari S; Ruan GJ; Artymiuk CJ; He R; Viswanatha DS; Abeykoon JP; Zanwar S; Young JR; Goyal G; Go RS; Rech KL;
Mod Pathol; 2023 Oct; 36(10):100268. PubMed ID: 37406859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
